We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tristel Plc | LSE:TSTL | London | Ordinary Share | GB00B07RVT99 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
15.00 | 3.23% | 480.00 | 460.00 | 480.00 | 470.00 | 465.00 | 465.00 | 33,518 | 16:35:01 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 36.01M | 4.46M | 0.0941 | 49.95 | 222.78M |
Date | Subject | Author | Discuss |
---|---|---|---|
24/5/2017 07:08 | Openday on 19 July - trading update also to be released. | glaws2 | |
22/5/2017 15:57 | The 2017 Sterile Processing State of the Industry Report - will need to register to read | piedro | |
22/5/2017 15:24 | Take a look at N4P, what's not to like???? | ch1rp | |
21/5/2017 20:29 | Talking of new Antibiotics paratek pharmaceuticals listed on the Us market as a late stage potentially exciting Antibiotic. But still nine to twelve months away if all goes well | best1467 | |
21/5/2017 19:57 | Interesting programme on BBC about super bugs and antibiotic resistance with some very interesting facts. No totally new type of antibiotic in more than 30 years It can take 20 years and cost up to $1billion to develop and approve a new antibiotic and the developer probably won't get it's money back. Very informative explanation on how resistance develops from genetic mutations and how the use of broad spectrum antibiotics encourages this by killing off competing microbes but leaving the resistant ones. Research into very quick DNA sequencing is enabling identification of specific infections so that a targeted approach can be used. 700,000 people die annually now from resistant infections with a projection of 10M a year by 2050 which doesn't give much time to develop a new family of antibiotics. If no profit in the $1billion cost, which businesses are going to do the research? So it's back to Florence Nightingales days of scrupulous hygiene using the best antiseptics available and attention to detail with cleaning to remove the possibility of infection. Just to recap, Tristel's "moat" is its patented methods of producing fresh chlorine dioxide at the point of use using various methods for different applications. Chlorine dioxide gives quicker complete sterilisation than alternative products without the drawbacks of bleach when used on furnishings. | melton john | |
11/5/2017 17:11 | Lack Of Understanding Over How To Clean Hands In Hospitals, Poll Finds MAY 11, 2017 More than 50% of British people visiting hospitals do not understand how to clean their hands properly, according to a recent YouGov poll. ... ... - perhaps TriStel can invent a foam or something ... | piedro | |
08/5/2017 16:24 | Antibiotic resistance has a language problem 03 May 2017 A failure to use words clearly undermines the global response to antimicrobials' waning usefulness. Standardize terminology, urge Marc Mendelson and colleagues. ... ... | piedro | |
08/5/2017 10:02 | Tristel Global @TristelGlobal The team ready to showcase products for #bacteria-free & #endotoxin-free rinse water for AER's at SGNA 2017 today! Stand 338 @SGNAOnline | piedro | |
13/4/2017 14:01 | Tristel Global Retweeted Ecomed @EcomedServices Bedankt aan alle bezoekers op onze stand op het #VHIG-congres! #infectiepreventie #Tristel #Pall #Hygie | piedro | |
07/4/2017 14:14 | Now we know why it was struggling | panic investor | |
29/3/2017 12:54 | Piedro - I talked to Paul Swinney at the interim presentation in Feb and he said then that they had been to a number of American Events. | glaws2 | |
29/3/2017 12:35 | metis20, glad you like them. Nice to see Tristel getting out and about and their first exhibition in the US. | piedro | |
28/3/2017 22:07 | Tristel Global @TristelGlobal Still time to speak to the Tristel team @! Come and say hello on Stand 425 #AIUM2017 | piedro | |
25/3/2017 15:16 | Tristel Solutions will be showcasing endocavityprobe disinfection at the American Institute of Ultrasound in Medicine (AIUM) Convention in Florida from the 25th to the 29th of March - Stand 425 AIUM2017 | piedro | |
24/3/2017 17:08 | Tristel Global @TristelGlobal Protect your investment. Maximise your time. With compatible and cost-effective solutions from Tristel. Find out more at #EAU2017! - EAU2017 on Stand C39 from 24th to the 28th of March. | piedro | |
24/3/2017 17:03 | They are certainly getting out and about .... 07/03 - Singapore 15/03 - Ulm, Germany 20/03 - Birmingham, UK 21/03 - Amiens, France 24/03 - Barcelona, Spain 24/03 - Adelaide, Australia | piedro | |
24/3/2017 16:59 | Tristel Global @TristelGlobal We are exhibiting at the 67th Annual Scientific Meeting #ASOHNS ASM 2017 until March 26th. Ask about our #ENT #disinfection solutions! | piedro | |
24/3/2017 10:12 | Anyone remember Plasmair? They are being sold by Ecomed, our French distributor | piedro | |
24/3/2017 09:45 | Vesismin Health @Vesismin Hoy estamos en la 15ª Jornada de Enfermería Quirúrgica, en el @hospitaldelmar - Barcelona . Os esperamos! #PreventingInfection Vesismin, our distributor in Spain | piedro | |
22/3/2017 14:02 | Although a lot of holders will have bought TSTL in an ISA, some won't, will want to take advantage of capital gains allowance and will sell before the tax year end in the hope possibly of buying back after 30 days. For anyone not aware, moving a share to an ISA (bed and ISA) crystalises your gain but buys the share straight back to put in the ISA and you still have time to do it. | melton john | |
22/3/2017 11:30 | Just recovering from one onslaught of 200. Back up soon!! | ch1rp | |
22/3/2017 11:16 | Rather soggy this morning | meijiman |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions